Stealth BioTherapeutics Corp.

NASDAQ:

MITO

Stealth BioTherapeutics Corp. is an innovative biopharmaceutical company developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.
Stealth BioTherapeutics' mission is to lead the development of mitochondrial medicine to improve the lives of patients with diseases involving mitochondrial dysfunction, an area of high unmet clinical need.

Key Facts

Auditor

Public Listing

Domicile

HQ/Management

Location of Key Operations

IR Contact

Deloitte Touche Tohmatsu CPA LLP

IPO (February 15, 2019)

Cayman Islands

Newton, Massachusetts, USA

Janhavi Mohite, Stern IR

212-362-1200

Analyst Coverage

Latest News